Institutional Ownership Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI). We have compiled data on the 144 institutions that hold shares in the stock, with a total of 85.3 Million shares, which have been reported (via 13F filing form) to have a value of $597 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
11,370,376
shares
|
$79.6 Million
6.78% of portfolio
|
Q1 2023
Reduced 0.02%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
10,259,409
shares
|
$71.8 Million
4.06% of portfolio
|
Q1 2025
Reduced 3.8%
|
|
Rubric Capital Management LP
New York, NY |
May 14, 2025 Q1 2025 |
4,538,535
shares
|
$31.8 Million
0.82% of portfolio
|
Q1 2025
Added 7.93%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,838,032
shares
|
$26.9 Million
0.0% of portfolio
|
Q1 2025
Added 9.37%
|
|
Vivo Capital, LLC
Palo Alto, CA |
May 12, 2025 Q1 2025 |
3,487,903
shares
|
$24.4 Million
5.95% of portfolio
|
Q4 2024
Added 116.25%
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
3,428,366
shares
|
$24 Million
3.99% of portfolio
|
Q1 2025
Added 10.77%
|
|
Octagon Capital Advisors LP
New York, NY |
May 16, 2025 Q1 2025 |
3,322,000
shares
|
$23.3 Million
6.95% of portfolio
|
Q1 2025
Reduced 28.36%
|
|
Viking Global Investors LP
|
May 15, 2025 Q1 2025 |
3,227,792
shares
|
$22.6 Million
0.07% of portfolio
|
Q1 2025
Reduced 26.64%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,135,115
shares
|
$21.9 Million
0.0% of portfolio
|
Q2 2024
Added 31.97%
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,988,000
shares
|
$20.9 Million
0.29% of portfolio
|
Q1 2025
New holding
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
2,863,793
shares
|
$20 Million
1.03% of portfolio
|
Q1 2025
Reduced 1.45%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
2,554,221
shares
|
$17.9 Million
0.02% of portfolio
|
Q1 2025
Added 5850.98%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
2,368,005
shares
|
$16.6 Million
0.04% of portfolio
|
Q1 2025
Reduced 42.94%
|
|
Acorn Capital Advisors, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,144,844
shares
|
$15 Million
9.39% of portfolio
|
Q1 2025
Added 7.19%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
2,057,812
shares
|
$14.4 Million
0.09% of portfolio
|
Q1 2025
Reduced 35.95%
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
1,758,619
shares
|
$12.3 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,614,865
shares
|
$11.3 Million
0.0% of portfolio
|
Q1 2025
Added 24.29%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,424,506
shares
|
$9.97 Million
0.0% of portfolio
|
Q1 2025
Added 21.68%
|
|
Mai Capital Management
|
May 15, 2025 Q1 2025 |
1,385,050
shares
|
$9.7 Million
0.07% of portfolio
|
Q1 2025
Added 2.08%
|
|
Affinity Asset Advisors, LLC
New York, NY |
May 14, 2025 Q1 2025 |
1,250,000
shares
|
$8.75 Million
0.88% of portfolio
|
Q1 2025
New holding
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,120,000
shares
|
$7.84 Million
0.22% of portfolio
|
Q1 2025
New holding
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
852,985
shares
|
$5.97 Million
0.0% of portfolio
|
Q1 2025
Added 3511.13%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
823,249
shares
|
$5.76 Million
0.0% of portfolio
|
Q1 2025
Added 356.3%
|
|
Opaleye Management Inc.
Boston, MA |
May 15, 2025 Q1 2025 |
795,000
shares
|
$5.57 Million
1.38% of portfolio
|
Q1 2025
Reduced 65.7%
|
|
Acuta Capital Partners, LLC
Belmont, CA |
May 15, 2025 Q1 2025 |
785,961
shares
|
$5.5 Million
9.38% of portfolio
|
Q1 2025
Added 1.81%
|